odronextamab
regeneron
['odronextamab', 'dlbcl']
9% infection related mortality in the fl and dlbcl cohorts with #odronextamab #icml2023 
#Lymphoma #CLL specialist @OUHospitals
Hon. senior lecturer @UniofOxford
Low grade+elderly high grade UK NCRI grp member
UK #CLL forum exec committee 
#lymsm